People · Operator
Named in public records as an officer, director or promoter · active 2007–2019 · Pharmaceuticals, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aerovate Therapeutics, Inc. | — | Pharmaceuticals | Series C | $78.3M | $2.6B | 2019 |
| Athenen Therapeutics, Inc. | — | Pharmaceuticals | Series A | $12.0M | $371.7M | 2019 |
| Arcuate Therapeutics, Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.9M | 2019 |
| TalentGuard Holdings, Inc. | — | Other | Seed | $4.4M | $63.2M | 2019 |
| Health Innovation Technologies Inc | — | Other Technology | Pre-Seed | $2.4M | $25.4M | 2007 |
James Schneider at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Schneider on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 3 | 17 |
| Joshua Resnick | 3 | 12 |
| Aaron Bergener | 2 | 2 |
| Sarah Reed | 2 | 2 |
| Krishna Srinivasan | 1 | 18 |
| Adam Rosenberg | 1 | 6 |
| Sari Epstein | 1 | 2 |
| Maha T. Katabi | 1 | 2 |
| Rod Favaron | 1 | 2 |
| Joan P. Hooper | 1 | 1 |
| Jamie P. Armstrong | 1 | 1 |
| Benjamin T. Dake | 1 | 1 |
| Joshua T. Resnick | 1 | 1 |
| Jonathan T. Leff | 1 | 1 |
| David T. Grayzel | 1 | 1 |
| Benjamin Dake | 1 | 1 |
| Frank Ginac | 1 | 1 |
| Linda Ginac | 1 | 1 |
| Paul A. Hartge | 1 | 1 |
| John A. Warren, O.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.